Our mission is to transform cancer care with enhanced detection, classification, and monitoring for improved treatment success Detect cancer early when it is treatable A novel genome-wide sequencing technique by the founders of Methylomics, to construct genome-wide DNA methylation profiles A proprietary Multiplex qPCR assay for the detection of cervical AND all other anogenital cancers​ with a superior sensitivity and specificity A multi-cancer diagnostic toolkit for the improved diagnosis, classification and monitoring of cancer from blood